Willem Klaassen's Colleagues at Xenikos B.V.
Willem Klaassen's Contact Details
HQ
N/A
N/A
Location
Nijmegen,Gelderland,Netherlands
Nijmegen,Gelderland,Netherlands
Company
Xenikos B.V.
Xenikos B.V.
Willem Klaassen's Company Details
Xenikos is a clinical-stage biotechnology company focused on developing a novel therapy that aims to quickly and efficiently reset the immune system of patients suffering from serious immune diseases, or rejection after transplantation. The Company's lead product candidate, T-Guard®, is currently in Phase 3 development for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD). Based on its mechanism of action, Xenikos believes T-Guard also has the potential to be effective in treating certain other serious immune conditions, such as transplant-related rejection, solid-organ rejection and several severe autoimmune diseases.
Frequently Asked Questions about Willem Klaassen
Willem Klaassen currently works for Xenikos B.V..
Willem Klaassen's role at Xenikos B.V. is Director Clinical Projects.
Willem Klaassen's email address is ***@xenikos.com. To view Willem Klaassen's full email address, please signup to ConnectPlex.
Willem Klaassen works in the Research industry.
Willem Klaassen's colleagues at Xenikos B.V. are Stan Musial, Ylja Oldenkamp, Bram Nillessen, Lisa Huberts, Jurgen Lagemaat, Ypke Oosterhout and others.
Willem Klaassen's phone number is N/A